Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.19.3.a.u2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Total revenues $ 4,678 $ 5,280 $ 14,357 $ 14,588
Total cost of revenues 2,520 2,433 7,538 7,583
Gross profit 2,158 2,847 6,819 7,005
Operating expenses        
Research and development 248 451 856 1,191
Selling, general and administrative 2,892 4,746 9,877 14,368
Total operating expenses 3,140 5,197 10,733 15,559
Loss from operations (982) (2,350) (3,914) (8,554)
Interest expense (1) (7) (13) (26)
Interest income 33 37 117 139
Other (expense) income (134) 22 (234) (135)
Gain on sale of assets (Note 4) 0 0 2,472 0
Net loss $ (1,084) $ (2,298) $ (1,572) $ (8,576)
Net loss per share: basic and diluted $ (0.72) $ (2.37) $ (1.14) $ (10.79)
Weighted-average number of shares used in per common share calculations: basic and diluted 1,500 971 1,378 795
Other comprehensive loss        
Net loss $ (1,084) $ (2,298) $ (1,572) $ (8,576)
Foreign currency translation adjustments 264 (291) 168 (443)
Comprehensive loss (820) (2,589) (1,404) (9,019)
Product [Member]        
Total revenues 4,381 5,045 13,478 13,775
Total cost of revenues 2,394 2,269 7,147 7,006
Service [Member]        
Total revenues 297 235 879 813
Total cost of revenues $ 126 $ 164 $ 391 $ 577